undamentalytics Newsletter
Sign in

Sanara Medtech Inc. cash flow statement

In fiscal 2025, Sanara Medtech Inc.'s operations generated $6.8m of cash; it spent $4.6m on capital projects, leaving free cash flow of $2.2m.

Cash flow statement

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash from operations−1,493−344−1,226−1,822−1,687−1,203409−140277−2,167−4,035−4,815−5,555−3,246−246,7875,695
Depreciation and amortisation472471615256606181841202915972,3713,6754,9233,9462,486
Stock-based pay—0531——————01,4032,6692,7033,4434,4365,1554,939
Capital spending———308534481835441721472652064,6261,191
Free cash flow———−1,852−1,695−1,208406−184269−2,350−4,579−4,986−5,702−3,511−2302,1614,504
Free cash flow after stock pay—————————−2,350−5,982−7,655−8,405−6,954−4,666−2,994−435
Share buybacks—————————10——————
Shares issued339960100——————————————

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: SMTI vs XTNTOWLT vs SMTIOM vs SMTICBLL vs SMTI

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Sanara Medtech Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Sanara Medtech Inc.